Marshall Wace North America
EPIX icon

Marshall Wace North America’s ESSA Pharma EPIX Stock Holding History

Marshall Wace North America’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-273,413
Closed -$7.81M – 1503
2021
Q2 		$7.81M Buy
273,413
+91,386
+50% +$2.66M 0.03% 423
2021
Q1 		$5.29M Buy
+182,027
New +$4.23M 0.02% 544

Other funds holding EPIX

Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Marshall Wace North America's EPIX Position: Q3 2021 in Review

Marshall Wace North America sold out of ESSA Pharma (EPIX) in Q3 2021, closing a stake of 273,413 shares — an estimated $7.81M sold.

Marshall Wace North America first reported a position in EPIX in Q1 2021 and held it in 2 quarters. The position peaked at $7.81M in Q2 2021. 75 funds tracked by Wall St. Rank hold EPIX as of Q3 2021.

  • Marshall Wace North America reported no remaining ESSA Pharma position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 273,413 ESSA Pharma shares in Q3 2021, an estimated $7.81M.
  • Marshall Wace North America first reported a position in ESSA Pharma in Q1 2021 and held it in 2 quarters.
  • Marshall Wace North America's ESSA Pharma position peaked at $7.81M in Q2 2021.
  • 75 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.